{"denomUnitsSelected":"Participants","description":"Assessment of long-term efficacy","reportingStatus":"NOT_POSTED","timeFrame":"up to 36 months after the start of therapy, the time of progression, initiation of alternative treatment or death, whichever came first","title":"Progression-free Survival (PFS)","type":"SECONDARY"}